{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:33:22Z","timestamp":1791038002604,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1124\/dmd.112.044677","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T02:43:54Z","timestamp":1335926634000},"page":"1473-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Boosting of HIV Protease Inhibitors by Ritonavir in the Intestine: The Relative Role of Cytochrome P450 and P-Glycoprotein Inhibition Based on Caco-2 Monolayers versus In Situ Intestinal Perfusion in Mice"],"prefix":"10.1016","volume":"40","author":[{"given":"Nico","family":"Holmstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.044677_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2006.12.011","article-title":"In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation","volume":"336","author":"Brouwers","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.112.044677_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1023\/A:1010914624111","article-title":"Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate","volume":"18","author":"Cummins","year":"2001","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.044677_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1023\/A:1023891320858","article-title":"P-glycoprotein attenuating effect of human intestinal fluid","volume":"20","author":"Deferme","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.044677_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.112.044677_bib5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/QAD.0b013e328332c3a5","article-title":"How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials","volume":"23","author":"Hill","year":"2009","journal-title":"AIDS"},{"key":"10.1124\/dmd.112.044677_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1124\/dmd.110.032771","article-title":"In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal P-glycoprotein by ritonavir causing increased darunavir absorption","volume":"38","author":"Holmstock","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044677_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2011.572905","article-title":"Ritonavir-boosted protease inhibitors in HIV therapy","volume":"43","author":"Hull","year":"2011","journal-title":"Ann Med"},{"key":"10.1124\/dmd.112.044677_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.112.044677_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.112.044677_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.044677_bib11","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.044677_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1023\/A:1010951732288","article-title":"Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures","volume":"18","author":"Mohri","year":"2001","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.112.044677_bib13","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/dmd.109.026591","article-title":"Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: evaluation of a novel tool in biopharmaceutical drug profiling","volume":"37","author":"Mols","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044677_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1211\/0022357011776252","article-title":"Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man","volume":"53","author":"Salphati","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.112.044677_bib15","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1073\/pnas.1010693107","article-title":"Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir","volume":"107","author":"Sevrioukova","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.044677_bib16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2007.01.027","article-title":"Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein","volume":"73","author":"Storch","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.044677_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.112.044677_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/dmd.108.024109","article-title":"Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects","volume":"37","author":"Vermeir","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.044677_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1211\/0022357022935","article-title":"Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects","volume":"56","author":"Vertzoni","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.112.044677_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dkh029","article-title":"Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients","volume":"53","author":"Zeldin","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624227495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.044677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:11:29Z","timestamp":1739909489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624227495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0090955624227495"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.044677","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boosting of HIV Protease Inhibitors by Ritonavir in the Intestine: The Relative Role of Cytochrome P450 and P-Glycoprotein Inhibition Based on Caco-2 Monolayers versus In Situ Intestinal Perfusion in Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.044677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}